SCIENTIFIC EVIDENCE

CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models

Cell reports. Medicine

Shang K, Huang D, Liu J, Yu Z, Bian W, Chen J, Zhao Y, Liu L, Jiang J, Wang Y, Duan Y, Ge J, Zhang S, Zhou C, Han Y, Hu Y, Zheng W, Sun J, Huang H, Pei S, Qian P, Sun J.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2025

Cancer Research

Immunology

Rigel S3

Key Finding

This study examines persistence of CD97-directed CAR T cells.

Countstar Connection

The researchers assessed cell viability with the Countstar Rigel S3.

View paper ↗

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online